Concepedia

Daniel Ford

DF

21

Publications

814

Citations

16

H-Index

2003

Active since

Affiliations

The University of Sydney(Current)

Australian Research Council

Renal Association

Monash University

UCB Pharma (United Kingdom)

Daniel Ford is an author at The University of Sydney specializing in medicine, drug discovery, and medicinal chemistry.

ORCID

Top concepts

Publications per year

2003–2024

21

Publications

21

UK Renal Registry 11th Annual Report (December 2008): Chapter 7 Survival and causes of death of UK adult patients on Renal Replacement Therapy in 2007: national and centre-specific analyses

David Ansell, Paul Roderick, Alex Hodsman et al. · Nephron Clinical Practice · 2009 · 199 citations

Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors

John Porter, Andrew Payne, Ben de Candole et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 117 citations · Full text

, , +4

External Beam Radiotherapy in the Management of Differentiated Thyroid Cancer

Daniel Ford, Selvaraj Giridharan, C. McConkey et al. · Clinical Oncology · 2003 · 78 citations

, , +7

Antiviral cyclic peptides targeting the main protease of SARS-CoV-2

Jason Johansen‐Leete, Sven Ullrich, Sarah E. Fry et al. · Chemical Science · 2022 · 60 citations · Full text

Chapter 3: UK ESRD Incident Rates in 2008: national and centre-specific analyses

Catherine Byrne, Daniel Ford, Julie Gilg et al. · Nephron Clinical Practice · 2010 · 40 citations

Rows per page

1–5 of 21